310 related articles for article (PubMed ID: 25968567)
1. Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment.
Schumann T; Adhikary T; Wortmann A; Finkernagel F; Lieber S; Schnitzer E; Legrand N; Schober Y; Nockher WA; Toth PM; Diederich WE; Nist A; Stiewe T; Wagner U; Reinartz S; Müller-Brüsselbach S; Müller R
Oncotarget; 2015 May; 6(15):13416-33. PubMed ID: 25968567
[TBL] [Abstract][Full Text] [Related]
2. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.
Adhikary T; Wortmann A; Schumann T; Finkernagel F; Lieber S; Roth K; Toth PM; Diederich WE; Nist A; Stiewe T; Kleinesudeik L; Reinartz S; Müller-Brüsselbach S; Müller R
Nucleic Acids Res; 2015 May; 43(10):5033-51. PubMed ID: 25934804
[TBL] [Abstract][Full Text] [Related]
3. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress.
Georgiadi A; Lichtenstein L; Degenhardt T; Boekschoten MV; van Bilsen M; Desvergne B; Müller M; Kersten S
Circ Res; 2010 Jun; 106(11):1712-21. PubMed ID: 20378851
[TBL] [Abstract][Full Text] [Related]
4. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
5. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
[TBL] [Abstract][Full Text] [Related]
6. PPARβ/δ in human cancer.
Müller R
Biochimie; 2017 May; 136():90-99. PubMed ID: 27916645
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
Bedu E; Wahli W; Desvergne B
Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
[TBL] [Abstract][Full Text] [Related]
8. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cells.
Hirao-Suzuki M; Takayuki K; Takiguchi M; Peters JM; Takeda S
Arch Biochem Biophys; 2022 Nov; 731():109428. PubMed ID: 36228705
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.
Khozoie C; Borland MG; Zhu B; Baek S; John S; Hager GL; Shah YM; Gonzalez FJ; Peters JM
BMC Genomics; 2012 Nov; 13():665. PubMed ID: 23176727
[TBL] [Abstract][Full Text] [Related]
11. Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages.
Bouhlel MA; Brozek J; Derudas B; Zawadzki C; Jude B; Staels B; Chinetti-Gbaguidi G
Biochem Biophys Res Commun; 2009 Aug; 386(3):459-62. PubMed ID: 19527689
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
[TBL] [Abstract][Full Text] [Related]
13. Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.
He P; Borland MG; Zhu B; Sharma AK; Amin S; El-Bayoumy K; Gonzalez FJ; Peters JM
Toxicology; 2008 Dec; 254(1-2):112-7. PubMed ID: 18950674
[TBL] [Abstract][Full Text] [Related]
14. Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.
Adhikary T; Brandt DT; Kaddatz K; Stockert J; Naruhn S; Meissner W; Finkernagel F; Obert J; Lieber S; Scharfe M; Jarek M; Toth PM; Scheer F; Diederich WE; Reinartz S; Grosse R; Müller-Brüsselbach S; Müller R
Oncogene; 2013 Oct; 32(44):5241-52. PubMed ID: 23208498
[TBL] [Abstract][Full Text] [Related]
15. PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development.
Liu Y; Hamid N; Manzoor R; Zhang BF; Liao YL; Wang JX; Pei DS
Sci Total Environ; 2024 Feb; 912():168949. PubMed ID: 38042186
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver.
Sanderson LM; Degenhardt T; Koppen A; Kalkhoven E; Desvergne B; Müller M; Kersten S
Mol Cell Biol; 2009 Dec; 29(23):6257-67. PubMed ID: 19805517
[TBL] [Abstract][Full Text] [Related]
17. Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist.
Zhao S; Kanno Y; Li W; Wakatabi H; Sasaki T; Koike K; Nemoto K; Li H
J Nat Prod; 2016 Apr; 79(4):879-85. PubMed ID: 27025413
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
19. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
[TBL] [Abstract][Full Text] [Related]
20. Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis.
Wawrzyniak M; Pich C; Gross B; Schütz F; Fleury S; Quemener S; Sgandurra M; Bouchaert E; Moret C; Mury L; Rommens C; Mottaz H; Dombrowicz D; Michalik L
J Allergy Clin Immunol; 2015 Jun; 135(6):1625-35.e5. PubMed ID: 25556996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
